19 August 2015
Persister mechanisms in Borrelia burgdorferi: implications for improved intervention
http://www.nature.com/emi/journal/v4/n8/full/emi201551a.html
----------------------------------------------------------------------------
2 July 2014
Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library
http://www.nature.com/emi/journal/v3/n7/full/emi201453a.html
-----------------------------------------------------------------------------
|
Lyme neuroborreliosis—epidemiology, diagnosis and management
http://www.nature.com/nrneurol/journal/v11/n8/full/nrneurol.2015.121.html
------------------------------------------------------------------------------
25 Mar 2015
Drug Combinations against Borrelia burgdorferi Persisters In Vitro: Eradication Achieved by Using Daptomycin, Cefoperazone and Doxycycline
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373819/
------------------------------------------------------------------------------
------------------------------------------------------------------------------
25 Mar 2015
Drug Combinations against Borrelia burgdorferi Persisters In Vitro: Eradication Achieved by Using Daptomycin, Cefoperazone and Doxycycline
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373819/
------------------------------------------------------------------------------
2015 Sep 16
Identification of Additional Anti-Persister Activity against Borrelia burgdorferi from an FDA Drug Library
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790293/
----------------------------------------------------------------------------
2016 Feb 10
Eradication of Biofilm-Like Microcolony Structures of Borrelia burgdorferi by Daunomycin and Daptomycin but not Mitomycin C in Combination with Doxycycline and Cefuroxime
https://www.ncbi.nlm.nih.gov/pubmed/26903956
---------------------------------------------------------------------------
19 August 2015
Persister mechanisms in Borrelia burgdorferi: implications for improved intervention
http://www.nature.com/emi/journal/v4/n8/full/emi201551a.html
https://www.researchgate.net/publication/282345075_Persister_mechanisms_in_Borrelia_burgdorferi_Implications_for_improved_intervention
--------------------------------------------------------------------------
2 July 2014
Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library
http://www.nature.com/emi/journal/v3/n7/full/emi201453a.html
--------------------------------------------------------------------------
2016
Identification of Additional Anti-Persister Activity against Borrelia burgdorferi from an FDA Drug Library
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790293/
----------------------------------------------------------------------------
2016 Feb 10
Eradication of Biofilm-Like Microcolony Structures of Borrelia burgdorferi by Daunomycin and Daptomycin but not Mitomycin C in Combination with Doxycycline and Cefuroxime
https://www.ncbi.nlm.nih.gov/pubmed/26903956
---------------------------------------------------------------------------
19 August 2015
Persister mechanisms in Borrelia burgdorferi: implications for improved intervention
http://www.nature.com/emi/journal/v4/n8/full/emi201551a.html
Persister mechanisms in Borrelia burgdorferi:
implications for improved intervention
Jie Feng, Wanliang Shi, Shuo Zhang and Ying Zhang
Emerging Microbes and Infections (2015) 4, e51; doi:10.1038/emi.2015.51; published online
19 August 2015
https://www.researchgate.net/publication/282345075_Persister_mechanisms_in_Borrelia_burgdorferi_Implications_for_improved_intervention
--------------------------------------------------------------------------
2 July 2014
Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library
http://www.nature.com/emi/journal/v3/n7/full/emi201453a.html
--------------------------------------------------------------------------
2016
The Use of Dapsone as a Novel “Persister” Drug in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome
----------------------------------------------------------------------------
Brak komentarzy:
Prześlij komentarz